Smith & Nephew plc (SNN)
NYSE: SNN · IEX Real-Time Price · USD
24.14
+0.01 (0.04%)
At close: May 1, 2024, 4:00 PM
24.55
+0.41 (1.70%)
Pre-market: May 2, 2024, 7:03 AM EDT

Smith & Nephew Revenue

In the year 2023, Smith & Nephew had annual revenue of $5.55B with 6.40% growth.

Revenue (ttm)
$5.55B
Revenue Growth
+6.47%
P/S Ratio
1.90
Revenue / Employee
$290,813
Employees
19,081
Market Cap
10.52B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.55B334.00M6.40%
Dec 31, 20225.22B3.00M0.06%
Dec 31, 20215.21B652.00M14.30%
Dec 31, 20204.56B-578.00M-11.25%
Dec 31, 20195.14B234.00M4.77%
Dec 31, 20184.90B139.00M2.92%
Dec 31, 20174.77B96.00M2.06%
Dec 31, 20164.67B35.00M0.76%
Dec 31, 20154.63B17.00M0.37%
Dec 31, 20144.62B266.00M6.11%
Dec 31, 20134.35B214.00M5.17%
Dec 31, 20124.14B-133.00M-3.11%
Dec 31, 20114.27B308.00M7.77%
Dec 31, 20103.96B190.00M5.04%
Dec 31, 20093.77B-29.00M-0.76%
Dec 31, 20083.80B432.00M12.82%
Dec 31, 20073.37B590.00M21.23%
Dec 31, 20062.78B227.00M8.89%
Dec 31, 20052.55B251.00M10.91%
Dec 31, 20042.30B1.12B95.17%
Dec 31, 20031.18B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tenet Healthcare 20.56B
Universal Health Services 14.28B
Solventum 8.20B
Catalent 4.10B
Incyte 3.70B
Bruker 2.96B
Exact Sciences 2.50B
United Therapeutics 2.33B
Revenue Rankings